Table 1.
Clinicopathological Characteristics Included in this Study
| Clinicopathological characteristics | Result * |
|---|---|
| Gender | |
| Males | 50 (75.8%) |
| Females | 16 (24.2%) |
| Age (y) | |
| Range | 38 - 89 |
| Median | 60 |
| Largest tumor diameter (cm) | |
| Range | 1-10 |
| Median | 4 |
| Variants of UC | |
| Conventional | 62 (93.9%) |
| Sarcomatoid | 4 (6.1%) |
| Divergent differentiation of UC | |
| Squamous differentiation | 29 (43.94%) |
| Glandular differentiation | 2 (3.03%) |
| Absent | 35 (53.03%) |
| Pattern of tumor invasion | |
| Nodular pattern | 46 (69.7%) |
| Trabecular pattern | 60 (91%) |
| Infiltrative pattern | 43 (65.2%) |
| Bilharziasis | |
| Present | 39 (59.1%) |
| Absent | 27 (40.9%) |
| Necrosis | |
| Present | 33 (50%) |
| Absent | 33 (50%) |
| PNI | |
| Present | 61 (92.4%) |
| Absent | 5 (7.6%) |
| LVI | |
| Present | 45 (68.2%) |
| Absent | 21 (31.8%) |
| Pathological tumor stage (pT) | |
| T2a | 3 (4.5%) |
| T2b | 11 (16.7%) |
| T3a | 5 (7.6%) |
| T3b | 36 (54.5%) |
| T4a | 11 (16.7%) |
| N0 | 41 (62.1%) |
| N1 | 6 (9.1%) |
| N2 | 19 (28.8%) |
| Distant metastasis stage (M) | |
| M0 | 62 (93.9%) |
| M1b | 4 (6.1%) |
| Stage grouping | |
| II | 10 (15.2%) |
| IIIA | 35 (53.0%) |
| IIIB | 17 (25.8%) |
| Stage grouping | |
| IVB | 4 (6.1%) |
| Patient follow up (2-year) | |
| Alive with disease | 4 (6.1%) |
| Alive till recurrence of disease | 8 (12.1%) |
| Alive without recurrence | 40 (60.6%) |
| Alive at the end of the study | 35 (53.0%) |
| Died at the end of the study | 17 (25.8%) |
| Lost to follow up | 14 (21.2%) |
| Overall survival (OS) (m) | |
| Range | 3-32 |
| Median | 24 |
| Disease free survival (DFS) (m) | |
| Range | 1-30 |
| Median | 22 |
LVI, lymphovascular invasion; PNI, perineural invasion, UC, urothelial carcinoma; * Data are numbers (%) of cases unless otherwise specified.